Login to Your Account



BIO CEO & Investor Conference

Recent Companion Dx Nods a Win for Personalized Medicine

By Michael Harris
Staff Writer

Wednesday, February 15, 2012
NEW YORK – Appropriately enough on Valentine's Day, there was news of a blossoming hook-up coming out of the BIO CEO & Investor Conference. The marriage of biopharma drugs and medical technology to develop the companion diagnostics market could be primed to deliver smart therapeutics and produce a family of hybrid products that have the capacity to prematurely discover disease, abort its onset or nurse its symptoms.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription